RAD51C (RAD51 paralog C)

symbol:
RAD51C
locus group:
protein-coding gene
location:
17q22
gene_family:
Fanconi anemia, complementation groups
alias symbol:
RAD51L2|FANCO
alias name:
None
entrez id:
5889
ensembl gene id:
ENSG00000108384
ucsc gene id:
uc002iwu.5
refseq accession:
NM_058216
hgnc_id:
HGNC:9820
approved reserved:
1998-02-26
17q22

RAD51C是RAD51基因家族的重要成员之一,属于DNA修复相关基因家族。这个家族的核心功能是参与同源重组修复(HRR),这是细胞修复DNA双链断裂(DSBs)的关键机制之一。RAD51C在HRR过程中与其他RAD51家族蛋白(如RAD51、RAD51B、RAD51D、XRCC2和XRCC3)形成复合物,帮助稳定断裂的DNA链并促进同源模板搜索和链交换。RAD51C主要作用位点是在DNA损伤修复的早期阶段,特别是在BRCA1/2依赖的修复通路中发挥重要作用。如果RAD51C发生突变,可能导致HRR功能缺陷,使细胞无法有效修复DNA损伤,从而增加基因组不稳定性,最终可能引发癌症。已有研究表明,RAD51C的突变与遗传性乳腺癌、卵巢癌以及其他癌症的易感性密切相关。当RAD51C表达降低时,细胞对DNA损伤的敏感性增加,可能导致染色体异常和细胞凋亡;而过度表达可能干扰正常的HRR过程,导致修复错误或基因组重排。RAD51C与其他DNA修复蛋白(如BRCA1/2、PALB2)协同作用,其功能异常可能影响整个修复网络的平衡。RAD51基因家族的共性在于它们都编码保守的RecA-like重组酶,这些蛋白在维持基因组稳定性、减数分裂和体细胞DNA修复中发挥核心作用。RAD51C的异常表达或功能缺陷不仅影响自身,还可能通过破坏修复复合物的形成而影响其他家族成员的功能,从而加剧基因组不稳定性。

ChineseEnglish

This gene is a member of the RAD51 family. RAD51 family members are highly similar to bacterial RecA and Saccharomyces cerevisiae Rad51 and are known to be involved in the homologous recombination and repair of DNA. This protein can interact with other RAD51 paralogs and is reported to be important for Holliday junction resolution. Mutations in this gene are associated with Fanconi anemia-like syndrome. This gene is one of four localized to a region of chromosome 17q23 where amplification occurs frequently in breast tumors. Overexpression of the four genes during amplification has been observed and suggests a possible role in tumor progression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]

Nucleotide sequence of RAD51C:[NCBI]
Loading Gene Browser...
Protein Sequence
1MRGKTFRFEM QRDLVSFPLS PAVRVKLVSA GFQTAEELLE
41VKPSELSKEV GISKAEALET LQIIRRECLT NKPRYAGTSE
81 SHKKCTALE LLEQEHTQGF IITFCSALDD ILGGGVPLMK
121TTEICGAPGV GKTQLCMQLA VDVQIPECFG GVAGEAVFID
161T EGSFMVDR VVDLATACIQ HLQLIAEKHK GEEHRKALED
201FTLDNILSHI YYFRCRDYTE LLAQVYLLPD FLSEHSKVRL
241VI VDGIAFP FRHDLDDLSL RTRLLNGLAQ QMISLANNHR
281LAVILTNQMT TKIDRNQALL VPALGESWGH AATIRLIFHW
321DRK QRLATL YKSPSQKECT VLFQIKPQGF RDTVVTSACS
361LQTEGSLSTR KRSRDPEEEL
结构预测来自 AlphaFold DB(UniProt: O43502),颜色表示 pLDDT 置信度(深蓝高、黄橙低)。
SNP variants of RAD51C:           Showing partial SNPs
rs172565       rs304269       rs304270       rs304271       rs304272       rs2005139       rs2611783       rs2611784       rs2611785       rs2877890       rs9797290       rs9895817       rs9904234       rs9907609       rs10515159       rs11655430       rs16943186      

Tissue expression of RAD51C:    [UniProt]

Gene expression across tissues
Forward Primer
Forward Tm
Reverse Primer
Reverse Tm
Score
GCTTAGCAAAGAAGTTGGGA
59
AGATGTACCAGCATATCTTGGT
59
CTGTCTCTTCGTACTCGGT
59
AACTTTCCCAGCTAATCTGTG
58
GCTTAGCAAAGAAGTTGGGA
59
AGATGTACCAGCATATCTTGGT
59
TTGTTCCTGCATTAGCCTC
58
GTGCTCAAGGAACCTTCTG
59
CTGTTTCAAATCAAACCTCAGG
58
GTGCTCAAGGAACCTTCTG
59
GCTTAGCAAAGAAGTTGGGA
59
AGATGTACCAGCATATCTTGGT
59
ACATGTATCGTCTCATTCCCA
59
AGATATCCCAACTTTGCATGAC
59
GCTTAGCAAAGAGCATTGC
58
ATGTGCACAACAAGTGACC
59
GATTTGGTGAGTTTCCCGC
60
CAACTGCATACTTTGCTAAGCT
60
GCTTAGCAAAGAAGTTGGGA
59
AGATGTACCAGCATATCTTGGT
59
      No data available

Subcellular localization of RAD51C (and its protein):

[UniProt]     [GenomeNet]

" d="M482.414,245.296c3.539,4.293,4.455,10.009,0.202,11 c-4.244,0.996-4.983-10.983-8.293-8.438c-5.271,4.08,9.834,12.271,5.144,17.287c-3.717,3.607-6.172-5.75-10.839-1.976 c-4.673,3.776,6.781,7.299,2.831,11.326c-4.354,4.045-6.979-1.449-9.837-5.517c-1.193-1.742-2.059-3.851-3.595-2.748 c-1.516,1.078-1.854,1.795-0.938,3.666c2.374,4.854,9.235,10.119,5.156,12.535c-5.636,3.346-5.044-8.871-9.426-7.574 c-4.388,1.291,2.557,10.66-1.245,11.141c-4.089,0.545-3.483-10.239-6.979-8.575c-2.522,1.206-0.929,3.071-0.938,4.899 c0.004,1.32-0.964,3.6-2.372,4.062c-3.593,1.171-8.544-1.065-10.251-3.59c-6.04-8.93,0.396-15.997,4.639-7.015 c3.023,4.642,5.182,0.834,2.839-2.219c-1.032-1.354-4.309-5.901-0.781-7.252c2.904-1.113,4.271,1.941,5.985,4.592 c2.61,4.016,5.485,0.117,3.031-3.414c-1.828-2.633-2.74-3.803,3.156-7.42c6.405-4.369,6.52,3.869,10.077,0.646 c2.309-1.832-4.783-5.149,0.06-8.995c2.896-2.293,5.18,6.207,7.961,3.516c3.523-2.737-7.717-7.369,0.117-11.736 C473.413,240.77,480.519,242.891,482.414,245.296z"/> Extracellular space Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi Apparatus Nucleus Mitochondrion 0 1 2 3 4 5 Confidence
  • plasma membrane
  • cytoplasm
  • extracellular
  • golgi
  • vesicle
  • cytoskeleton
  • endoplasmic reticulum
  • nucleus
  • endosome
  • lysosome
  • mitochondrion

Gene Ontology (GO) terms for RAD51C:

GO ID
Protein
Source DB
GO:0003677
A0A087WZ35 (UniProtKB)
IEA
GO:0005524
A0A087WZ35 (UniProtKB)
IEA
GO:0006281
A0A087WZ35 (UniProtKB)
IEA
GO:0008094
A0A087WZ35 (UniProtKB)
IEA
GO:0003677
H7C1R0 (UniProtKB)
IEA
GO:0005524
H7C1R0 (UniProtKB)
IEA
GO:0006281
H7C1R0 (UniProtKB)
IEA
GO:0008094
H7C1R0 (UniProtKB)
IEA
GO:0003677
H7C2Q5 (UniProtKB)
IEA
GO:0005524
H7C2Q5 (UniProtKB)
IEA
GO:0006281
H7C2Q5 (UniProtKB)
IEA
GO:0008094
H7C2Q5 (UniProtKB)
IEA
GO:0003677
J3QKK3 (UniProtKB)
IEA
GO:0005524
J3QKK3 (UniProtKB)
IEA
GO:0006281
J3QKK3 (UniProtKB)
IEA
GO:0008094
J3QKK3 (UniProtKB)
IEA
GO:0003677
J3QLQ2 (UniProtKB)
IEA
GO:0005524
J3QLQ2 (UniProtKB)
IEA
GO:0006281
J3QLQ2 (UniProtKB)
IEA
GO:0008094
J3QLQ2 (UniProtKB)
IEA
GO:0003677
J3QR58 (UniProtKB)
IEA
GO:0005524
J3QR58 (UniProtKB)
IEA
GO:0006281
J3QR58 (UniProtKB)
IEA
GO:0008094
J3QR58 (UniProtKB)
IEA
GO:0000150
O43502 (UniProtKB)
IBA
GO:0000722
O43502 (UniProtKB)
IEA
GO:0000724
O43502 (UniProtKB)
IMP
GO:0000730
O43502 (UniProtKB)
IBA
GO:0000731
O43502 (UniProtKB)
TAS
GO:0000732
O43502 (UniProtKB)
TAS
GO:0000794
O43502 (UniProtKB)
IBA
GO:0003677
O43502 (UniProtKB)
TAS
GO:0003690
O43502 (UniProtKB)
IBA
GO:0003697
O43502 (UniProtKB)
IBA
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005515
O43502 (UniProtKB)
IPI
GO:0005524
O43502 (UniProtKB)
IEA
GO:0005634
O43502 (UniProtKB)
IDA
GO:0005634
O43502 (UniProtKB)
IDA
GO:0005654
O43502 (UniProtKB)
IBA
GO:0005654
O43502 (UniProtKB)
TAS
GO:0005654
O43502 (UniProtKB)
TAS
GO:0005654
O43502 (UniProtKB)
TAS
GO:0005654
O43502 (UniProtKB)
TAS
GO:0005654
O43502 (UniProtKB)
TAS
GO:0005654
O43502 (UniProtKB)
TAS
GO:0005654
O43502 (UniProtKB)
TAS
GO:0005654
O43502 (UniProtKB)
TAS
GO:0005654
O43502 (UniProtKB)
TAS
GO:0005654
O43502 (UniProtKB)
TAS
GO:0005654
O43502 (UniProtKB)
TAS
GO:0005654
O43502 (UniProtKB)
TAS
GO:0005654
O43502 (UniProtKB)
TAS
GO:0005654
O43502 (UniProtKB)
TAS
GO:0005654
O43502 (UniProtKB)
TAS
GO:0005657
O43502 (UniProtKB)
IDA
GO:0005737
O43502 (UniProtKB)
IDA
GO:0005739
O43502 (UniProtKB)
IDA
GO:0006281
O43502 (UniProtKB)
IDA
GO:0006310
O43502 (UniProtKB)
IDA
GO:0006312
O43502 (UniProtKB)
IBA
GO:0007062
O43502 (UniProtKB)
ISS
GO:0007066
O43502 (UniProtKB)
IEA
GO:0007131
O43502 (UniProtKB)
IBA
GO:0007141
O43502 (UniProtKB)
IEA
GO:0007283
O43502 (UniProtKB)
IEA
GO:0007596
O43502 (UniProtKB)
TAS
GO:0008094
O43502 (UniProtKB)
IBA
GO:0010212
O43502 (UniProtKB)
IBA
GO:0010971
O43502 (UniProtKB)
IMP
GO:0033063
O43502 (UniProtKB)
IDA
GO:0033065
O43502 (UniProtKB)
IDA
GO:0042148
O43502 (UniProtKB)
IBA
GO:0048471
O43502 (UniProtKB)
IDA
GO:0070192
O43502 (UniProtKB)
IBA
GO:0048476
O43502 (UniProtKB)
IDA
GO:0000400
O43502 (UniProtKB)
IDA
GO:0008821
O43502 (UniProtKB)
IMP
GO:0003677
Q7KZJ0 (UniProtKB)
IEA
GO:0005524
Q7KZJ0 (UniProtKB)
IEA
GO:0006281
Q7KZJ0 (UniProtKB)
IEA
GO:0008094
Q7KZJ0 (UniProtKB)
IEA

microRNAs potentially regulating RAD51C:     

String
BioGrid
IntAct
mentha
MINT
Reactome
Loading…
Interacting Gene Interaction Source/Score
Disease Score NofPmids NofSnps Source
Disease Score NofPmids NofSnps Source
FANCONI ANEMIA, COMPLEMENTATION GROUP O 0.36 1 6 CLINVAR_CTD_human_UNIPROT
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3 0.36 2 5 CLINVAR_CTD_human_UNIPROT
Fanconi Anemia 0.243800186 14 1 BeFree_CTD_human_ORPHANET
Hereditary Breast and Ovarian Cancer Syndrome 0.121357209 5 0 BeFree_ORPHANET
ovarian neoplasm 0.120271442 2 0 BeFree_CTD_human
Neoplastic Syndromes, Hereditary 0.12 0 28 CLINVAR
Mammary Neoplasms 0.12 1 0 CTD_human
Malignant neoplasm of breast 0.016721114 23 5 BeFree_GAD
Malignant neoplasm of ovary 0.011791553 27 0 BeFree_GAD
Ovarian Carcinoma 0.007328931 27 0 BeFree
Uptake of cascade tests in relatives of patients undergoing cancer precision medicine in Japan.
Matsubayashi H, Kiyozumi Y, Ishihara E, Harada R, Higashigawa S, Fushiki K, Nishimura S, Kado N, Onozawa Y, Kawata T, Kenmotsu H, Ko R, Serizawa M Jpn J Clin Oncol IF: 2.5 2026-05-07
Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer.
Davies HR, Black D, Kvist A, Sigurjónsdóttir K, Bosch A, Bowden R, Memari Y, Chen Z, Rinaldi G, Rosengren F, Nacer DF, Veerla S, Hohmann L, Nordborg N, Häkkinen J, Vallon-Christersson J, Borg Å, Nik-Zainal S, Staaf J Commun Med (Lond) IF: 7.4 2026-02-16
Evaluation of homologous recombination testing in ovarian carcinoma.
Witjes VM, de Hullu JA, van Remortele A, Vreede L, Rosenberg EH, Cillessen SAGM, Groenendijk FH, Steeghs EMP, Moonen L, Mensenkamp AR, Ter Elst A, de Leng WWJ, Hoogerbrugge N, Ligtenberg MJL Virchows Arch IF: 3.0 2026-04-00
RAD51C-XRCC3 complex regulates FANCM-mediated R-loop resolution to safeguard genome integrity.
Sahoo S, Nagraj T, Bhattacharya D, Nagar N, Somyajit K, Poluri KM, Nagaraju G Sci Adv IF: 12.5 2026-02-20
[Hereditary breast cancer : Syndromes, pathology, clinical aspects].
Lebeau A, Schmutzler R Pathologie (Heidelb) IF: 0.7 2026-09-00
Unravelling genetic susceptibility and causal factors in liver health using MRI quantification of inflammation, fat and iron in the liver.
Meena D, Pansini M, Fichera A, Huang J, Ahmed A, Dehghan A, Banerjee R, Yaghootkar H Hum Genomics IF: 4.1 2026-02-28
Structural insight into how RAD51 paralog exchange regulates RAD51 filament formation.
Rawal Y, Kwon Y, Jia L, Ruben EA, Ji JH, Guo L, Stratton CM, Nayak D, Tovar M, Fang Q, Jamalruddin MA, Zhou S, Kuppa S, Syed S, Jasper AM, Katz JN, Rogers CM, Kaur H, Samentar L, Zhao W, Dray E, Zhang F, Stoilova-McPhie S, Taylor AB, Burma S, Rao MK, Libich DS, Hromas R, Mazin AV, Jasin M, Zhou D, Bernstein KA, Greene EC, Wasmuth EV, Sung P, Olsen SK Nat Struct Mol Biol IF: 0.000 2026-05-00
Immuno-molecular features associated with exceptional recurrence-free survivorship from Ovarian Cancer in the pre-PARP era.
Blanc-Durand F, Yaniz Galende E, Ferron G, Kaminsky MC, Kalbacher E, Abadie-Lacourtoisie S, Joly F, Meunier J, Tredan O, Lebreton C, Alexandre J, Zannetti A, Louvet C, Blonz C, Dohollou N, Berton D, Desauw C, Carola E, Fabbro M, Follana P, Pujade-Lauraine E, Mourani L, Le Formal A, Gaultier De Saint Basile H, Genestie C, Rouleau E, Leary A NPJ Genom Med 2026-04-23
BCDX2-CX3 and DX2-CX3 complexes assemble and stabilize RAD51 filaments.
Koo CW, Xiao J, Coassolo S, Liu J, Yu C, Azumaya CM, Gore SK, Cheung TK, Brillantes B, Rose CM, Heyer WD, Ciferri C, Yatskevich S Nature IF: 56.1 2026-05-00
The Impact of Conventional Chemotherapy Regimens and Targeted Drugs on Ovarian Function in Breast Cancer Patients.
Haskoylu S, Sahin SB, Altıntas A, Yildiz S, Bildik G, Benlioglu C, Turan V, Kim S, Oktem O Reprod Sci IF: 2.8 2026-04-00

Loading comments...

Log in to post comments Log In Sign Up

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com